Molecular dynamics simulations on SDF-1α: Binding with CXCR4 receptor

Biophysical Journal

Volumn 84, Issue 1, 2003, Pages 171-184

  Huang, Xiaoqin ^a,b   Shen, Jianhua ^a   Cui, Meng ^a   Shen, Lingling ^a   Luo, Xiaomin ^a   Ling, Kun ^b   Pei, Gang ^b   Jiang, Hualiang ^a   Chen, Kaixian ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CHEMOKINE RECEPTOR CXCR4; GLUTAMIC ACID; MEMBRANE PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ARTICLE; AUTOMATION; BINDING SITE; CONFORMATIONAL TRANSITION; ELECTRICITY; ENERGY; MOLECULAR DYNAMICS; MOLECULAR MODEL; PREDICTION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SIMULATION; SURFACE PROPERTY;

EID: 0037214576     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(03)74840-1     Document Type: Article

References (68)

1. Adamian, L., and J. Liang. 2001. Helix-helix packing and interfacial pairwise interactions of residues in membrane proteins. J. Mol. Biol. 311:891-907.
2. Babcock, G. J., T. Mirzabekov, W. Wojtowicz, and J. Sodroski. 2001. Ligand-binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes. J. Biol. Chem. 276:38433-38440.
3. Baker, D., and A. Sali. 2001. Protein structure prediction and structural genomics. Science. 294:93-96.
4. Bennett, T. A., T. A. Key, V. V. Gurevic, G. R. Neubig, E. R. Prossnitz, and L. Sklar. 2001. Real-time analysis of G protein-coupled receptor reconstitution in a solubilized system. J. Biol. Chem. 276:22453-22460.
5. Brelot, A., N. Heveker, M. Montes, and M. Alizon. 2000. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. J. Biol. Chem. 275: 23736-23744.
6. Brooks, B. R., R. E. Bruccoleri, B. D. Olasfon, D. J. States, S. Swaminathan, and M. Karplus. 1983. CHARMM: A program for macromolecular energy, minimization and dynamics calculations. J. Comput. Chem. 4:187-217.
7. Chabot, D., and C. C. Broder. 2000. Substitutions in a homologous region of extracellular loop 2 of CXCR4 and CCR5 alter coreceptor activities for HIV-1 membrane fusion and virus entry. J. Biol. Chem. 275:23774-23782.
8. Cheng, Z. J., J. Zhao, Y. Sun, W. Hu, Y. L. Wu, B. Cen, G. X. Wu, and G. Pei. 2000. β-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between β-arrestin and CXCR4. J. Biol. Chem. 275:2479-2485.
9. Cornell, W. D., D. P. Cieplak, C. I. Bayly, I. R. Gould, K. M. Merz, D. M. Ferguson, D. C. Spellmeyer, T. Fox, J. W. Caldwell, and P. A. Kollman. 1995. A new force field for molecular mechanical simulation on nucleic acids and proteins. J. Am. Chem. Soc. 117:5179-5197.
10. Crump, M. P., J. H. Gong, P. Loetscher, K. Rajarathnam, A. Amara, F. Arenzana-Seisdedos, J. L. Virelizier, M. Baggiolini, B. D. Sykes, and I. Clark-Lewis. 1997. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1, EMBO J. 16:6996-7007.
11. Cui, M., J. H. Shen, J. M. Biggs, X. M. Luo, X. J. Tan, H. L. Jiang, K. X. Chen, and R. Y. Ji. 2001. Brownian dynamics with hydrodynamic interactions. Biophys. J. 80:1659-1669.
12. Cui, M., J. H. Shen, J. M. Biggs, W. Fu, J. J. Wu, Y. M. Zhang, X. M. Luo, Z. W. Chi, R. Y. Ji, H. L. Jiang, and K. X. Chen. 2002. Brownian dynamics simulations of the recognition of the scorpion toxin P05 with the small-conductance calcium activated potassium channels. J. Mol. Biol. 318:417-428.
13. Dealwis, C., E. J. Fernandez, D. A. Thompson, R. J. Simon, M. A. Siani, and E. Lolis. 1998. Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1α, a potent ligand for the HIV-1 "fusion" coreceptor. Proc. Natl. Acad. Sci. USA. 95:6941-6946.
14. Dragic, T., A. Trkola, D. A. D. Thompson, E. G. Cormier, F. A. Kajumo, E. Maxwell, S. W. Lin, W. W. Ying, S. O. Smith, T. P. Sakmar, and J. P. Moore. 2000. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helics of CCR5. Proc. Natl. Acad. Sci. USA. 97:5639-5644.
15. Duan, Y., and P. A. Kollman. 1998. Pathways to a protein folding intermediate observed in a 1-microsecond simulation in aqueous solution. Science. 282:740-744.
16. Eichinger, M., H. Grubmüller, H. Heller, and P. Tavan. 1997. FAMU-SAMM: An algorithm for rapid evaluation of electrostatic interactions in molecular dynamics simulations. J. Comput. Chem. 18:1729-1749.
17. Eichinger, M., H. Heller, and H. Grubmüller. 2000. EGO - An efficient molecular dynamics program and its application to protein dynamics simulations. In Workshop on Molecular Dynamics on Parallel Computers. R. Esser, P. Grassberger, J. Grotendorst, and M. Lewerenz, editors. World Scientific, Singapore, Germany. 397-412.
18. Elisseeva, E. L., C. M. Slupsky, M. P. Crump, I. Clark-Lewis, and B. D. Sykes. 2000. NMR studies of active N-terminal peptides of stromal cell-derived factor-1. Structural basis for receptor binding. J. Biol. Chem. 275:26799-26805.
19. Ermak, L., and J. A. McCammon. 1978. Brownian dynamics with hydrodynamic interactions. J. Chem. Phys. 69:1352-1360.
20. Filizola, M., M. Carteni-Farina, and J. J. Perez. 1999. Modeling the 3D structure of rhodopsin using a de-novo approach to build G-protein-coupled receptors. J. Phys. Chem. 103:2520-2527.
21. Fu, W., M. Cui, J. M. Briggs, X. Q. Huang, B. Xiong, Y. M. Zhang, X. M. Luo, J. H. Shen, R. Y. Ji, H. L. Jiang, and K. X. Chen. 2002. Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels. Biophys. J. 83: 2370-2385.
22. Gerard, C., and B. J. Rollins. 2001. Chemokines and disease. Nat. Immunol. 2:108-115.
23. Jayasinghe, S., K. Hristova, and S. H. White. 2001. Energetics, stability, and prediction of transmembrane helices. J. Mol. Biol. 312:927-934.
24. Gerlach, L. O., R. T. Skerlj, G. J. Bridger, and T. W. Schwartz. 2001. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. J. Biol. Chem. 276:14153-14160.
25. Gether, U., and B. K. Kobilka. 1998. G protein-coupled receptors. II. Mechanism of agonist activation. J. Biol. Chem. 273:17979-17982.
26. Grobner, G., U. Burnett, C. Glaubitz, G. Cho, A. J. Bason, and A. Watts. 2000. Observations of light-induced structural changes of retinal within rhodopsin. Nature. 405:810-813.
27. Gupta, S. K., K. Pillarisetti, R. A. Thomas, and N. Aiyar. 2001. Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: Implications for development of selective CXCR4 antagonists. Immunol. Lett. 78:29-34.
28. Hatse, S., K. Princen, L. O. Gerlach, G. Bridger, G. Henson, E. Clercq, T. W. Schwartz, and D. Schols. 2001. Mutation of Asp (171) and Asp (262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100. Mol. Pharm. 60:164-173.
29. Henikoff, S., and J. G. Henikoff. 1992. Amino-acid substitution matrices from protein blocks. Proc. Natl. Acad. Sci. USA. 89:10915-10919.
30. Huang, X. Q., H. L. Jiang, X. M. Luo, K. X. Chen, R. Y. Ji, Y. Cao, and G. Pei. 2000. Building three-dimensional structures of HIV-1 coreceptor CCR5 and its complex with antagonist TAK779 by comparative molecular modeling. Acta Pharmacol. Sin. 21:521-528.
31. Jorgensen, W. L., J. Chandrasekhar, J. D. Madura, R. W. Impey, and M. L. Klein. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926-935.
32. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK - A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
33. Liang, J., H. Edelsbrunner, and C. Woodward. 1998. Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design. Protein Sci. 7:1884-1897.
34. Ling, K., P. Wang, J. Zhao, Y. L. Wu, Z. J. Chen, G. X. Wu, W. Hu, L. Ma, and G. Pei. 1999. Five-transmembrane domains appear sufficient for a G protein-coupled receptor: Functional five-transmembrane domain chemokine receptors. Proc. Natl. Acad. Sci. USA. 96:7922-7926.
35. Liotta, L. A. 2001. An attractive force in metastasis. Nature. 410:24-25.
36. Loetscher, M., T. Geiser, T. O'Reilly, R. Zwahlen, M. Baggiolini, and B. Moser. 1994. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269:232-237.
37. Loetscher, P., J. H. Gong, B. Dewald, M. Baggiolini, and I. Clark-Lewis. 1998. N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J. Biol. Chem. 273:22279-22283.
38. Mackay, C. 2001. Chemokines: Immunology's high impact factors. Nat. Immunol. 2:95-101.
39. Matthew, J. B. 1985. Electrostatic effects in proteins. Annu. Rev. Biophys. Biophys. Chem. 14:387-417.
40. Matthew, J. B., and F. R. Gurd. 1986. Calculation of electrostatic interactions in proteins. Methods Enzymol. 130:413-436.
41. McDonald, I. K., and J. M. Thornton. 1994. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238:777-793.
42. Moore, J. P., and M. Stevenson. 2000. New targets for inhibitors of HIV-1 replication. Nat. Rev. Mol. Cell Biol. 1:40-49.
43. Morris, G. M., D. S. Goodsell, R. S. Halliday, R. Huey, W. E. Hart, R. K. Belew, and A. J. Olson. 1998. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19:1639-1662.
44. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic controlled by chemokines. Nat. Immunol. 2:123-128.
45. Muller, A., B. Homey, H. Soto, N. F. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, J. L. Barrera, A. Mohar, E. Verastegui, and A. Zlotnik. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50-56.
46. Neria, E., S. Fisher, and M. Karplus. 1996. Simulation of activation energies in molecular systems. J. Chem. Phys. 105:1902-1921.
47. Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11:281-296.
48. Orry, A. J. W., and B. A. Wallace. 2000. Modeling and docking the endothelin G-protein-coupled receptor. Biophys. J. 79:3083-3094.
49. Ottemann, K. M., W. Z. Xiao, Y. K. Shin, and D. E. Koshland, Jr. 1999. A pistil model for transmembrane signaling of the aspartate receptor. Science. 285:1751-1754.
50. Palczewski, K., T. Kumasaka, T. Hori, C. A. Behnke, H. Motoshima, B. A. Fox, I. Trong, D. C. Teller, T. Okada, R. E. Stenkamp, M. Yamamoto, and M. Miyano. 2000. Crystal structure of rhodopsin: A G protein-coupled receptor. Science. 289:730-734.
51. Pearson, W. R. 1990. Rapid and sensitive sequence comparison with FASTAP and FASTA. Methods Enzymol. 183:63-98.
52. Perera, L., C. Foley, T. A. Darden, D. Stafford, T. Mather, C. T. Esmon, and L. G. Pedersen. 2000. Modeling zymogen protein C. Biophys. J. 79:2925-2943.
53. Ryckaert, J. P., G. Ciccotti, and H. J. C. Berendsen. 1977. Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comput. Phys. 23:327-341.
54. Schwarz, M. K., and T. N. C. Wells. 1999. Interfering with chemokine networks - The hope for new therapeutics. Curr. Opin. Chem. Biol. 3:407-417.
55. Shapiro, D. A., K. Kristiansen, W. K. Kroeze, and B. L. Roth. 2000. Differential modes of agonist binding to 5-hydroxytryptamine2A serotonin receptors revealed by mutation and molecular modeling of conserved in transmembrane residues region 5. Mol. Pharm. 58: 877-886.
56. Smoluchowski, M. V. 1917. Versuch einer mathematischen theorie der koagulationskinetik kolloider loeschungen. Z. Phys. Chem. 92: 129-168.
57. Solis, F. J., and R. J. B. Wets. 1981. Minimization by random search techniques. Maths. Opera. Res. 6:19-30.
58. Teller, D. C., T. Okada, C. A. Behnke, K. Palczewski, and R. E. Stenkamp. 2001. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry. 46:7761-7772.
59. Thelen, M. 2001. Dancing to the tune of chemokines. Nat. Immunol. 2:129-134.
60. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties, and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
61. Ulmschneider, M. B., and M. S. P. Sansom. 2001. Amino acid distributions in integral membrane protein structures. Biochim. Biophys. Acta. 1512:1-14.
62. Verlet, L. 1967. Computer experiments on classical fluids. I. Thermodynamical properties of Lennard-Jones molecules. Phys. Rev. 159: 98-103.
63. Vriend, G., and C. Sander. 1993. Quality control of protein models - Directional atomic contact analysis. J. Appl. Crystallogr. 26:47-60.
64. Wallace, A. C., R. A. Laskowski, and J. M. Thornton. 1995. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8:127-134.
65. Warwicker, J., and H. C. Watson. 1982. Calculation of the electric potential in the active site cleft due to alpha-helix dipoles. J. Mol. Biol. 157: 671-679.
66. Zhao, J., L. H. Ben, Y. L. Wu, W. Hu, K. Ling, S. M. Xin, L. N. Nie, L. Ma, and G. Pei. 1999, Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors. J. Exp. Med. 190:101-111.
67. Zhou, N. M., Z. W. Luo, J. S. Luo, D. X. Liu, J. W. Hall, R. J. Pomerantz, and Z. W. Huang. 2001. Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 coreceptor by mutagenesis and molecular modeling studies. J. Biol. Chem. 276:42826-42833.
68. Zlotnik, A., and O. Yoshie. 2000. Chemokines: A new classification system and their role in immunity. Immunity. 12:121-127.